NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc.verified

NRXP

Price:

$1.32

Market Cap:

$14.19M

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.[Read more]

Industry

Biotechnology

IPO Date

2017-12-04

Stock Exchange

NASDAQ

Ticker

NRXP

The PE Ratio as of November 2024 (TTM) for NRx Pharmaceuticals, Inc. (NRXP) is -0.49

According to NRx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.49. This represents a change of -94.18% compared to the average of -8.43 of the last 4 quarters.

NRx Pharmaceuticals, Inc. (NRXP) Historical PE Ratio (quarterly & annually)

How has NRXP PE Ratio performed in the past?

The mean historical PE Ratio of NRx Pharmaceuticals, Inc. over the last ten years is 99.37. The current -0.49 PE Ratio has changed -149.31% with respect to the historical average. Over the past ten years (40 quarters), NRXP's PE Ratio was at its highest in in the June 2020 quarter at 9.15K. The PE Ratio was at its lowest in in the June 2018 quarter at -9723.06.

Quarterly (TTM)
Annual

Average

99.37

Median

-20.72

Minimum

-677.26

Maximum

1.38K

NRx Pharmaceuticals, Inc. (NRXP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of NRx Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = 1.38K

Minimum Annual Increase = -1753.85%

Minimum Annual PE Ratio = -677.26

Quarterly (TTM)
Annual
YearPE RatioChange
2023-1.16-94.42%
2022-20.72-33.75%
2021-31.27-95.38%
2020-677.26-612.85%
2019132.06-90.41%
20181.38K-1753.85%

NRx Pharmaceuticals, Inc. (NRXP) Average PE Ratio

How has NRXP PE Ratio performed in the past?

The current PE Ratio of NRx Pharmaceuticals, Inc. (NRXP) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-17.72

5-year avg

-119.67

10-year avg

99.37

NRx Pharmaceuticals, Inc. (NRXP) PE Ratio vs. Peers

How is NRXP’s PE Ratio compared to its peers?

NRx Pharmaceuticals, Inc.’s PE Ratio is less than BiomX Inc. (0), less than Lexaria Bioscience Corp. (-0.27), greater than Aditxt, Inc. (-6.51), less than Nutriband Inc. (-0.02), less than Quoin Pharmaceuticals, Ltd. (0), greater than Longeveron Inc. (-8.87), less than RenovoRx, Inc. (-0.44), greater than Virax Biolabs Group Limited (-0.72), greater than SAB Biotherapeutics, Inc. (-3.08), greater than Senti Biosciences, Inc. (-0.68), greater than Cingulate Inc. (-0.93), less than Bellicum Pharmaceuticals, Inc. (-0.18), greater than Hillstream BioPharma, Inc. (-1.18), less than null (-0.11), less than null (-0.00),

Build a custom stock screener for NRx Pharmaceuticals, Inc. (NRXP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NRx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NRx Pharmaceuticals, Inc. (NRXP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NRx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is NRx Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for NRx Pharmaceuticals, Inc. (NRXP)?

What is the highest PE Ratio for NRx Pharmaceuticals, Inc. (NRXP)?

What is the 3-year average PE Ratio for NRx Pharmaceuticals, Inc. (NRXP)?

What is the 5-year average PE Ratio for NRx Pharmaceuticals, Inc. (NRXP)?

How does the current PE Ratio for NRx Pharmaceuticals, Inc. (NRXP) compare to its historical average?